Literature DB >> 9441012

[Risk factors for diabetic foot in recipients of renal and pancreatic transplants].

V Bartos1, A Jirkovská, R Koznarová.   

Abstract

BACKGROUND: The risk of tissue damage of the foot in diabetic subjects is due to a combination of arterial insufficiency and peripheral neuropathy. The probable development of diabetic foot with possible subsequent amputation is greater in uraemic diabetics. The objective of the presented work was to assess the incidence and risk of diabetic foot in diabetic patients where on account of renal failure transplantation of the kidney was performed. METHODS AND
RESULTS: In a retrospective study in 1983-1992 for a period of 6 months to 7 years a group of 64 diabetics was investigated (37 men and 27 women), mean age 42.8 years, range 29-58 years where on account of diabetic nephropathy renal (n = 49, 76.6%) or renal and pancreatic transplantation (n = 15, 23.4%) was performed. At the time of transplantation 53 patients (82.8%) suffered from peripheral neuropathy, 24 (37.5%) from angiopathy of the lower extremities. During the follow up period 22 patients (34.4%) developed ulcerations of the skin of the lower extremities, incl. 15 patients (23.4%) with a local and 4 (6.3%) with a phlegmonous infection. In 10 patients (15.6%) amputation had to be performed.
CONCLUSIONS: Ulceration of the foot in diabetics cannot be prevented by transplantation of the kidney or transplantation of the kidney and pancreas. Ulceration of the foot is at present an important contraindication for transplantation.

Entities:  

Mesh:

Year:  1997        PMID: 9441012

Source DB:  PubMed          Journal:  Cas Lek Cesk        ISSN: 0008-7335


  1 in total

1.  Protection of pancreatic β-cell by phosphocreatine through mitochondrial improvement via the regulation of dual AKT/IRS-1/GSK-3β and STAT3/Cyp-D signaling pathways.

Authors:  Hongyan Wang; Jie Ai; Abdullah Shopit; Mengyue Niu; Nisar Ahmed; Tsehaye Tesfaldet; Zhongyuan Tang; Xiaodong Li; Yazeed Jamalat; Peng Chu; Jinyong Peng; Xiaodong Ma; Eskandar Qaed; Guozhu Han; Weisheng Zhang; Jun Wang; Zeyao Tang
Journal:  Cell Biol Toxicol       Date:  2021-08-28       Impact factor: 6.691

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.